Trends in varicella and mumps vaccination rates in children under 3 years of age in a tertiary children's hospital in Japan

被引:8
作者
Morikawa, Yoshihiko [1 ]
Morino, Saeko [2 ,3 ]
Ito, Kenta [2 ,4 ]
Furuichi, Mihoko [2 ,5 ]
Miyokawa, Shigeko [6 ]
Shoji, Takayo [2 ,7 ]
Horikoshi, Yuho [2 ]
机构
[1] Tokyo Metropolitan Childrens Med Ctr, Clin Res Support Ctr, Tokyo, Japan
[2] Tokyo Metropolitan Childrens Med Ctr, Div Infect Dis, Dept Pediat, Tokyo, Japan
[3] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan
[4] Aichi Childrens Hlth & Med Ctr, Dept Gen Pediat, Obu, Aichi, Japan
[5] Saitama Childrens Med Ctr, Div Infect Dis & Immunol, Saitama, Japan
[6] Tokyo Metropolitan Childrens Med Ctr, Nursing Div, Tokyo, Japan
[7] Shizuoka Childrens Hosp, Dept Pediat Infect Dis, Shizuoka, Japan
关键词
chickenpox vaccine; measles vaccine; mumps vaccine; rubella vaccine; universal vaccination program; HERPES-ZOSTER; UNITED-STATES; IMPACT; IMMUNIZATION; EPIDEMIOLOGY; ADOLESCENTS; EXPOSURE; PROGRAM; VIRUS;
D O I
10.1111/ped.13916
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background In Japan, the voluntary vaccination rate is not known accurately. Although two doses of the measles and rubella vaccines have been part of the universal vaccine program since 2006, the varicella vaccine was added in October 2014 while the mumps vaccine still remains voluntary. The aim of this study was to evaluate trends in the live measles, rubella, varicella and mumps vaccination rates in Japan. Methods This retrospective cohort study was conducted at Tokyo Metropolitan Children's Medical Center between October 2012 and December 2016. Patients aged 1-2 years who were admitted to the Department of General Pediatrics were enrolled. The trend in the vaccination rate against measles, rubella, varicella, and mumps was examined. Results The measles and rubella vaccination rate was 80-90%. The varicella vaccination rate in the second quarter of 2012, the third quarter of 2014, and the fourth quarter of 2016 was 34.6%, 67.1%, and 80.7%, respectively. The mumps vaccination rate in the second quarter of 2012, the third quarter of 2014, and the fourth quarter of 2016 was 27.6%, 59.5%, and 61.8%, respectively. Conclusions The varicella and mumps vaccination rate improved until 2014 despite the fact that they were voluntary vaccinations. After varicella vaccination was added to the universal vaccination program, the varicella vaccination rate continued to improve. The mumps vaccination, which was not included, failed to improve, suggesting that the universal vaccination program contributed to increasing the uptake of the vaccines it includes.
引用
收藏
页码:882 / 888
页数:7
相关论文
共 32 条
  • [11] Herpes zoster in the first year of life following postnatal exposure to varicella-zoster virus - Four case reports and a review of infantile herpes zoster
    Kurlan, JG
    Connelly, BL
    Lucky, AW
    [J]. ARCHIVES OF DERMATOLOGY, 2004, 140 (10) : 1268 - 1272
  • [12] Near Elimination of Varicella Deaths in the US After Implementation of the Vaccination Program
    Marin, Mona
    Zhang, John X.
    Seward, Jane F.
    [J]. PEDIATRICS, 2011, 128 (02) : 214 - 220
  • [13] Varicella immunisation practice: Implications for provision of a recommended, non-funded vaccine
    Marshall, Helen
    Ryan, Philip
    Roberton, Don
    Beilby, Justin
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2009, 45 (05) : 297 - 303
  • [14] Ministry of Health Labor and Welfare, MEASL
  • [15] Ministry of Health Labour and Welfare, SUIT VAR
  • [16] Descriptive epidemiology of varicella based on national surveillance data before and after the introduction of routine varicella vaccination with two doses in Japan, 2000-2017
    Morino, Saeko
    Tanaka-Taya, Keiko
    Satoh, Hiroshi
    Arai, Satoru
    Takahashi, Takuri
    Sunagawa, Tomimasa
    Oishi, Kazunori
    [J]. VACCINE, 2018, 36 (40) : 5977 - 5982
  • [17] National Institute of Infectious Diseases, 2016, AG DISTR VAR VACC HI
  • [18] National Institute of Infectious Diseases, 2016, IASR, V37, P185
  • [19] National Institute of Infectious Diseases, 2015, IASR, V36, P143
  • [20] National Institute of Infectious Diseases, 2016, INFECT AGENTS SURVEI, V37, P116